{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:51:54Z","timestamp":1772027514593,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"28","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460497"],"award-info":[{"award-number":["82460497"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172921"],"award-info":[{"award-number":["82172921"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No. 82260500"],"award-info":[{"award-number":["Grant No. 82260500"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["Grant No. 20242BAB26142"],"award-info":[{"award-number":["Grant No. 20242BAB26142"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010251","name":"Youth Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["Grant No.20232ACB216014"],"award-info":[{"award-number":["Grant No.20232ACB216014"]}],"id":[{"id":"10.13039\/501100010251","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of Jiangxi Provincial Key Laboratory of Urinary System Diseases"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,7,28]]},"DOI":"10.1038\/s41388-025-03410-3","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T12:41:16Z","timestamp":1745066476000},"page":"2372-2385","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RETRACTED ARTICLE: Non-classic deubiquitinase USP13 inhibits bladder cancer metastasis through destabilizing cytoplasmic KDM3A"],"prefix":"10.1038","volume":"44","author":[{"given":"Hongji","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangpeng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunqiang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruize","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanzhuo","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianxi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Situ","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongshui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0269-9129","authenticated-orcid":false,"given":"Songhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0881-0936","authenticated-orcid":false,"given":"Ju","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"3410_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2020.101760","volume":"67","author":"SR Horn","year":"2020","unstructured":"Horn SR, Stoltzfus KC, Lehrer EJ, Dawson LA, Tchelebi L, Gusani NJ, et al. Epidemiology of liver metastases. Cancer Epidemiol. 2020;67:101760.","journal-title":"Cancer Epidemiol"},{"key":"3410_CR2","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/j.ymthe.2021.01.031","volume":"29","author":"J Zhu","year":"2021","unstructured":"Zhu J, Luo Y, Zhao Y, Kong Y, Zheng H, Li Y, et al. circEHBP1 promotes lymphangiogenesis and lymphatic metastasis of bladder cancer via miR-130a-3p\/TGF\u03b2R1\/VEGF-D signaling. Mol Ther. 2021;29:1838\u201352.","journal-title":"Mol Ther"},{"key":"3410_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1053\/j.semnuclmed.2021.12.004","volume":"52","author":"K Bouchelouche","year":"2022","unstructured":"Bouchelouche K. PET\/CT in Bladder Cancer: An Update. Semin Nucl Med. 2022;52:475\u201385.","journal-title":"Semin Nucl Med"},{"key":"3410_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes JA, Bruins HM, Cathomas R, Comp\u00e9rat EM, Cowan NC, Gakis G, et al. European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol. 2021;79:82\u2013104.","journal-title":"Eur Urol"},{"key":"3410_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/bmb\/ldy034","volume":"128","author":"SJ Crabb","year":"2018","unstructured":"Crabb SJ, Douglas J. The latest treatment options for bladder cancer. Br Med Bull. 2018;128:85\u201395.","journal-title":"Br Med Bull"},{"key":"3410_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41585-018-0055-4","volume":"15","author":"C Pettenati","year":"2018","unstructured":"Pettenati C, Ingersoll MA. Mechanisms of BCG immunotherapy and its outlook for bladder cancer. Nat Rev Urol. 2018;15:615\u201325.","journal-title":"Nat Rev Urol"},{"key":"3410_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","volume":"21","author":"KC Ohaegbulam","year":"2015","unstructured":"Ohaegbulam KC, Assal A, Lazar-Molnar E, Yao Y, Zang X. Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. Trends Mol Med. 2015;21:24\u201333.","journal-title":"Trends Mol Med"},{"key":"3410_CR8","doi-asserted-by":"crossref","unstructured":"Thomas J, Sonpavde G. Molecularly targeted therapy towards genetic alterations in advanced bladder cancer. Cancers (Basel) 2022;1795:14.","DOI":"10.3390\/cancers14071795"},{"key":"3410_CR9","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1002\/cncr.28147","volume":"119","author":"K Chamie","year":"2013","unstructured":"Chamie K, Litwin MS, Bassett JC, Daskivich TJ, Lai J, Hanley JM, et al. Recurrence of high-risk bladder cancer: a population-based analysis. Cancer. 2013;119:3219\u201327.","journal-title":"Cancer"},{"key":"3410_CR10","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1038\/551S34a","volume":"551","author":"C Berdik","year":"2017","unstructured":"Berdik C. Unlocking bladder cancer. Nature. 2017;551:S34\u2013s35.","journal-title":"Nature"},{"key":"3410_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ctrv.2016.09.018","volume":"50","author":"R Morales-Barrera","year":"2016","unstructured":"Morales-Barrera R, Su\u00e1rez C, de Castro AM, Racca F, Valverde C, Maldonado X, et al. Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope. Cancer Treat Rev. 2016;50:208\u201316.","journal-title":"Cancer Treat Rev"},{"key":"3410_CR12","doi-asserted-by":"publisher","first-page":"e45011","DOI":"10.2196\/45011","volume":"9","author":"S Renner","year":"2023","unstructured":"Renner S, Loussikian P, Foulqui\u00e9 P, Marrel A, Barbier V, Mebarki A, et al. Patient and caregiver perceptions of advanced bladder cancer systemic treatments: infodemiology study based on social media data. JMIR Cancer. 2023;9:e45011.","journal-title":"JMIR Cancer"},{"key":"3410_CR13","doi-asserted-by":"crossref","unstructured":"Yoo J, Jeon YH, Cho HY, Lee SW, Kim GW, Lee DH, et al. Advances in histone demethylase KDM3A as a cancer therapeutic target. Cancers (Basel) 2020;1098:12.","DOI":"10.3390\/cancers12051098"},{"key":"3410_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02881-8","volume":"19","author":"S Hu","year":"2021","unstructured":"Hu S, Cao P, Kong K, Han P, Deng Y, Li F, et al. MicroRNA-449a delays lung cancer development through inhibiting KDM3A\/HIF-1\u03b1 axis. J Transl Med. 2021;19:224.","journal-title":"J Transl Med"},{"key":"3410_CR15","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1038\/onc.2011.512","volume":"31","author":"M Bj\u00f6rkman","year":"2012","unstructured":"Bj\u00f6rkman M, \u00d6stling P, H\u00e4rm\u00e4 V, Virtanen J, Mpindi JP, Rantala J, et al. Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion. Oncogene. 2012;31:3444\u201356.","journal-title":"Oncogene"},{"key":"3410_CR16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/nar\/gku1298","volume":"43","author":"MA Wade","year":"2015","unstructured":"Wade MA, Jones D, Wilson L, Stockley J, Coffey K, Robson CN, et al. The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer. Nucleic Acids Res. 2015;43:196\u2013207.","journal-title":"Nucleic Acids Res"},{"key":"3410_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/onc.2016.174","volume":"36","author":"S Ramadoss","year":"2017","unstructured":"Ramadoss S, Guo G, Wang CY. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53. Oncogene. 2017;36:47\u201359.","journal-title":"Oncogene"},{"key":"3410_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.556004","volume":"8","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Pan Q, Shao Z. Tumor-Suppressive Role of microRNA-202-3p in Hepatocellular Carcinoma Through the KDM3A\/HOXA1\/MEIS3 Pathway. Front Cell Dev Biol. 2020;8:556004.","journal-title":"Front Cell Dev Biol"},{"key":"3410_CR19","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1007\/s00262-022-03167-8","volume":"71","author":"LH Qu","year":"2022","unstructured":"Qu LH, Fang Q, Yin T, Yi HM, Mei GB, Hong ZZ, et al. Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma. Cancer Immunol Immunother. 2022;71:2449\u201367.","journal-title":"Cancer Immunol Immunother"},{"key":"3410_CR20","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.bbrc.2019.02.088","volume":"511","author":"L Sun","year":"2019","unstructured":"Sun L, Yuan Y, Chen J, Ma C, Xu Y. Brahma related gene 1 (BRG1) regulates breast cancer cell migration and invasion by activating MUC1 transcription. Biochem Biophys Res Commun. 2019;511:536\u201343.","journal-title":"Biochem Biophys Res Commun"},{"key":"3410_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ijbiomac.2018.12.105","volume":"126","author":"J Liu","year":"2019","unstructured":"Liu J, Liang T, Zhangsun W. KDM3A is associated with tumor metastasis and modulates colorectal cancer cell migration and invasion. Int J Biol Macromol. 2019;126:318\u201325.","journal-title":"Int J Biol Macromol"},{"key":"3410_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrm2731","volume":"10","author":"D Komander","year":"2009","unstructured":"Komander D, Clague MJ, Urb\u00e9 S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol. 2009;10:550\u201363.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3410_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02693-9","volume":"9","author":"S Zhang","year":"2018","unstructured":"Zhang S, Zhang M, Jing Y, Yin X, Ma P, Zhang Z, et al. Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors. Nat Commun. 2018;9:215.","journal-title":"Nat Commun"},{"key":"3410_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153705","volume":"229","author":"T Zhang","year":"2022","unstructured":"Zhang T, Zheng J, Qiao L, Zhao W. Deubiquitinase USP13 promotes the epithelial-mesenchymal transition and metastasis in gastric cancer by maintaining Snail protein. Pathol Res Pr. 2022;229:153705.","journal-title":"Pathol Res Pr"},{"key":"3410_CR25","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1080\/15548627.2020.1743071","volume":"16","author":"W Xie","year":"2020","unstructured":"Xie W, Jin S, Cui J. The NEDD4-USP13 axis facilitates autophagy via deubiquitinating PIK3C3. Autophagy. 2020;16:1150\u20131.","journal-title":"Autophagy"},{"key":"3410_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15752","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Luo K, Yin Y, Wu C, Deng M, Li L, et al. USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response. Nat Commun. 2017;8:15752.","journal-title":"Nat Commun"},{"key":"3410_CR27","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.1038\/s41388-020-01396-8","volume":"39","author":"M Esposito","year":"2020","unstructured":"Esposito M, Akman HB, Giron P, Ceregido MA, Schepers R, Ramos Paez LC, et al. USP13 controls the stability of Aurora B impacting progression through the cell cycle. Oncogene. 2020;39:6009\u201323.","journal-title":"Oncogene"},{"key":"3410_CR28","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1038\/s41388-023-02739-x","volume":"42","author":"C Ma","year":"2023","unstructured":"Ma C, Wang D, Tian Z, Gao W, Zang Y, Qian L, et al. USP13 deubiquitinates and stabilizes cyclin D1 to promote gastric cancer cell cycle progression and cell proliferation. Oncogene. 2023;42:2249\u201362.","journal-title":"Oncogene"},{"key":"3410_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13046-019-1262-4","volume":"38","author":"X Man","year":"2019","unstructured":"Man X, Piao C, Lin X, Kong C, Cui X, Jiang Y. USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer. J Exp Clin Cancer Res. 2019;38:259.","journal-title":"J Exp Clin Cancer Res"},{"key":"3410_CR30","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/ncb2874","volume":"15","author":"J Zhang","year":"2013","unstructured":"Zhang J, Zhang P, Wei Y, Piao HL, Wang W, Maddika S, et al. Deubiquitylation and stabilization of PTEN by USP13. Nat Cell Biol. 2013;15:1486\u201394.","journal-title":"Nat Cell Biol"},{"key":"3410_CR31","doi-asserted-by":"publisher","first-page":"9175","DOI":"10.2147\/CMAR.S186829","volume":"11","author":"Z Qu","year":"2019","unstructured":"Qu Z, Zhang R, Su M, Liu W. USP13 serves as a tumor suppressor via the PTEN\/AKT pathway in oral squamous cell carcinoma. Cancer Manag Res. 2019;11:9175\u201383.","journal-title":"Cancer Manag Res"},{"key":"3410_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2405-4","volume":"11","author":"L Fan","year":"2020","unstructured":"Fan L, Xu S, Zhang F, Cui X, Fazli L, Gleave M, et al. Histone demethylase JMJD1A promotes expression of DNA repair factors and radio-resistance of prostate cancer cells. Cell Death Dis. 2020;11:214.","journal-title":"Cell Death Dis"},{"key":"3410_CR33","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s13046-021-02194-0","volume":"40","author":"X Man","year":"2021","unstructured":"Man X, Piao C, Lin X, Kong C, Cui X, Jiang Y. Correction to: USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer. J Exp Clin Cancer Res. 2021;40:386.","journal-title":"J Exp Clin Cancer Res"},{"key":"3410_CR34","doi-asserted-by":"publisher","first-page":"10606","DOI":"10.1074\/jbc.RA118.001730","volume":"293","author":"K Peng","year":"2018","unstructured":"Peng K, Su G, Ji J, Yang X, Miao M, Mo P, et al. Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt\/\u03b2-catenin signaling. J Biol Chem. 2018;293:10606\u201319.","journal-title":"J Biol Chem"},{"key":"3410_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3892\/ol.2020.12199","volume":"20","author":"HJ Ahn","year":"2020","unstructured":"Ahn HJ, Moon B, Park M, Kim JA. KDM3A regulates Slug expression to promote the invasion of MCF7 breast cancer cells in hypoxia. Oncol Lett. 2020;20:335.","journal-title":"Oncol Lett"},{"key":"3410_CR36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2119854119","volume":"119","author":"H Xie","year":"2022","unstructured":"Xie H, Zhou J, Liu X, Xu Y, Hepperla AJ, Simon JM, et al. USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer. Proc Natl Acad Sci USA. 2022;119:e2119854119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3410_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113511","volume":"42","author":"Y Guo","year":"2023","unstructured":"Guo Y, Tian J, Guo Y, Wang C, Chen C, Cai S, et al. Oncogenic KRAS effector USP13 promotes metastasis in non-small cell lung cancer through deubiquitinating \u03b2-catenin. Cell Rep. 2023;42:113511.","journal-title":"Cell Rep"},{"key":"3410_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/biof.2139","volume":"51","author":"A Wang","year":"2025","unstructured":"Wang A, Wang Y, Ma Q, Chen X. The carcinogenesis of esophageal squamous cell cancer is positively regulated by USP13 through WISP1 deubiquitination. Biofactors. 2025;51:e2139.","journal-title":"Biofactors"},{"key":"3410_CR39","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s13402-023-00779-9","volume":"46","author":"B Zhao","year":"2023","unstructured":"Zhao B, Huo W, Yu X, Shi X, Lv L, Yang Y, et al. USP13 promotes breast cancer metastasis through FBXL14-induced Twist1 ubiquitination. Cell Oncol (Dordr). 2023;46:717\u201333.","journal-title":"Cell Oncol (Dordr)"},{"key":"3410_CR40","doi-asserted-by":"publisher","first-page":"13366","DOI":"10.1080\/21655979.2022.2062535","volume":"13","author":"S Song","year":"2022","unstructured":"Song S, Wang Y, Wang HY, Guo LL. Role of sevoflurane in myocardial ischemia-reperfusion injury via the ubiquitin-specific protease 22\/lysine-specific demethylase 3A axis. Bioengineered. 2022;13:13366\u201383.","journal-title":"Bioengineered"},{"key":"3410_CR41","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.freeradbiomed.2023.09.024","volume":"208","author":"B Lee","year":"2023","unstructured":"Lee B, Kim YH, Lee W, Choi HY, Lee J, Kim J, et al. USP13 deubiquitinates p62\/SQSTM1 to induce autophagy and Nrf2 release for activating antioxidant response genes. Free Radic Biol Med. 2023;208:820\u201332.","journal-title":"Free Radic Biol Med"},{"key":"3410_CR42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cell.2011.08.037","volume":"147","author":"J Liu","year":"2011","unstructured":"Liu J, Xia H, Kim M, Xu L, Li Y, Zhang L, et al. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell. 2011;147:223\u201334.","journal-title":"Cell"},{"key":"3410_CR43","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1016\/j.celrep.2020.01.088","volume":"30","author":"W Xie","year":"2020","unstructured":"Xie W, Jin S, Wu Y, Xian H, Tian S, Liu DA, et al. Auto-ubiquitination of NEDD4-1 Recruits USP13 to Facilitate Autophagy through Deubiquitinating VPS34. Cell Rep. 2020;30:2807\u20132819.e2804.","journal-title":"Cell Rep."},{"key":"3410_CR44","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.sbi.2010.08.006","volume":"20","author":"MA McDonough","year":"2010","unstructured":"McDonough MA, Loenarz C, Chowdhury R, Clifton IJ, Schofield CJ. Structural studies on human 2-oxoglutarate dependent oxygenases. Curr Opin Struct Biol. 2010;20:659\u201372.","journal-title":"Curr Opin Struct Biol"}],"updated-by":[{"DOI":"10.1038\/s41388-025-03520-y","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"record-id":"67993"},{"DOI":"10.1038\/s41388-025-03520-y","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000}}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03410-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03410-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03410-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:24:11Z","timestamp":1757161451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03410-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":44,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2025,7,28]]}},"alternative-id":["3410"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03410-3","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41388-025-03520-y","URL":"https:\/\/doi.org\/10.1038\/s41388-025-03520-y","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}